The news: Apple is reportedly working with its research partners UCLA and Biogen on iPhone features that will detect depression and cognitive decline by monitoring users’ behavior, per WSJ.
The problem: Apple rolled out a new privacy campaign last year to boost consumers’ trust—but an invasive depression diagnosis tool could stymie those efforts.
Last November, Apple required apps in the iOS App Store to add privacy “nutrition labels” to inform users what type of sensitive information the app collects.
But if users know Apple is analyzing their typing behavior and facial expressions to detect depression, it could raise brows and slow down Apple’s privacy initiative:
The opportunity: If Apple does move forward with the depression detection feature, it’ll need to offer a way for users to seek professional help after receiving a diagnoses—or else it’ll be limited in utility.
Only half of US individuals diagnosed with depression get treatment for their condition, in part due to barriers like lack of mental health providers and affordability of mental health services.
NEW REPORT: We examine the data privacy landscape and explore how consumers view their healthcare privacy data in our new report, Healthcare Data Privacy 2021: Providers Race Against Ransomware.